Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Response of plasma microRNAs to nusinersen treatment in patients with SMA
Irina Zaharieva, Mariacristina Scoto, Karolina Aragon‐Gawinska, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 9, Iss. 7, pp. 1011-1026
Open Access | Times Cited: 12

Showing 12 citing articles:

Molecular Biomarkers for the Diagnosis, Prognosis, and Pharmacodynamics of Spinal Muscular Atrophy
Marija Babić, Maria Banović, Ivana Berečić, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 15, pp. 5060-5060
Open Access | Times Cited: 13
Treating neuromuscular diseases: unveiling gene therapy breakthroughs and pioneering future applications
Yu‐Fu Wu, Jun‐An Chen, Yuh‐Jyh Jong
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access
Role of circulating biomarkers in spinal muscular atrophy: insights from a new treatment era
Giorgia Querin, M. Gómez García de la Banda, Piera Smeriglio
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 8
Insights into spinal muscular atrophy from molecular biomarkers
Xiaodong Xing, Xinzhu Liu, Xiandeng Li, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 7, pp. 1849-1863
Open Access | Times Cited: 3
Full-Length SMN Transcript in Extracellular Vesicles as Biomarker in Individuals with Spinal Muscular Atrophy Type 2 Treated with Nusinersen
Selena Trifunov, Daniel Natera‐de Benito, Laura Carrera‐García, et al.
Journal of Neuromuscular Diseases (2023) Vol. 10, Iss. 4, pp. 653-665
Open Access | Times Cited: 6
270th ENMC International Workshop: Consensus for SMN2 genetic analysis in SMA patients 10–12 March, 2023, Hoofddorp, the Netherlands
Emanuela Abiusi, Mar Costa‐Roger, Enrico Bertini, et al.
Neuromuscular Disorders (2023) Vol. 34, pp. 114-122
Open Access | Times Cited: 6
MicroRNAs as Biomarkers in Spinal Muscular Atrophy
Maruša Barbo, Damjan Glavač, Gregor Jezernik, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2428-2428
Open Access | Times Cited: 1
The Relevance of Spinal Muscular Atrophy Biomarkers in the Treatment Era
Marianna Maretina, V. I. Koroleva, Л. М. Щугарева, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2486-2486
Open Access | Times Cited: 1
Molecular markers of disease severity and response to nusinersen therapy in 5q spinal muscular atrophy (literature review)
Konstantin Popov, Т. М. Алексеева, В. Д. Назаров, et al.
Neuromuscular Diseases (2023) Vol. 13, Iss. 3, pp. 33-39
Open Access | Times Cited: 1
Spinal muscular atrophy 5q. Clinical and genetic characteristics, molecular genetic diagnosis and etiopathogenetic treatment. 2nd ed.
Sergey Kucev, С. С. Никитин, Е. Л. Дадали, et al.
(2024)
Closed Access
An early Transcriptomic Investigation in Adult Patients with Spinal Muscular Atrophy Under Treatment with Nusinersen
Maria Liguori, Annalisa Bianco, Alessandro Introna, et al.
Journal of Molecular Neuroscience (2024) Vol. 74, Iss. 4
Open Access
Nusinersen treatment response markers
Ian Fyfe
Nature Reviews Neurology (2022) Vol. 18, Iss. 7, pp. 381-381
Closed Access
Page 1

Scroll to top